AstraZeneca Accounts Payable 2010-2025 | AZN

AstraZeneca accounts payable for the quarter ending March 31, 2025 were $22.544B, a 14.44% increase year-over-year.

  • AstraZeneca accounts payable for 2024 were $22.465B, a 0.41% increase from 2023.
  • AstraZeneca accounts payable for 2023 were $22.374B, a 17.51% increase from 2022.
  • AstraZeneca accounts payable for 2022 were $19.04B, a 0.54% increase from 2021.

AstraZeneca Accounts Payable 2010-2025 | AZN

  • AstraZeneca accounts payable for 2024 were $22.465B, a 0.41% increase from 2023.
  • AstraZeneca accounts payable for 2023 were $22.374B, a 17.51% increase from 2022.
  • AstraZeneca accounts payable for 2022 were $19.04B, a 0.54% increase from 2021.